Artículos por temáticas

Digital health in presymptomatic diseases

Cohen M.

Rev Neurol (Paris). 2025 Nov;181(9):937-943. doi: 10.1016/j.neurol.2025.06.017. Epub 2025 Nov 12.

Strategies to rescue mitochondria in Parkinson's disease: The significance of mitochondrial transfer

Liang J, Su Z, Su G, Rasheed M, Tang S, Sunniya H, Maazouzi M, Cui Y, Wang J, Wang X, Yang J, Ding M, Li Z, Deng Y.

Ageing Res Rev. 2025 Dec;112:102856. doi: 10.1016/j.arr.2025.102856. Epub 2025 Aug 5.

Effects of glucocerebrosidase gene variations on the risk of Parkinson's disease dementia: a meta-analysis

Li Q, Bi Z, Liang W, Yin S, Li H, Liang Z, Wu M, Quan J, Li C.

Front Aging Neurosci. 2025 Nov 14;17:1671760. doi: 10.3389/fnagi.2025.1671760. eCollection 2025.

Rethinking neurodegeneration through a co-proteinopathy lens

Zhang YP, Kedia S, Klenerman D.

Trends Neurosci. 2025 Nov 6:S0166-2236(25)00219-X. doi: 10.1016/j.tins.2025.10.006. Online ahead of print.

Beyond Parkinson's Disease: A Narrative Review of Neuromelanin MRI in Neurodegenerative Diseases

Burade A, Lakhani DA, Dagher R, Anosh J, Sair HI, Luna LP.

J Neuroimaging. 2025 Nov-Dec;35(6):e70113. doi: 10.1111/jon.70113.

The role of microglia in neurodegenerative diseases: from the perspective of ferroptosis

Liu YJ, Jia GR, Zhang SH, Guo YL, Ma XZ, Xu HM, Xie JX.

Acta Pharmacol Sin. 2025 Nov;46(11):2877-2892. doi: 10.1038/s41401-025-01560-4. Epub 2025 Apr 30.

Neuroimaging in advanced Parkinson's disease: insights into pathophysiology, biomarkers, and personalized therapies

Schröter N, Groppa S, Rijntjes M, Gonzalez-Escamilla G, Urbach H, Jost WH, Rau A.

J Neural Transm (Vienna). 2025 Nov;132(11):1655-1664. doi: 10.1007/s00702-025-02942-y. Epub 2025 May 12.

Neurological letter from Canada

Furtado S.

Pract Neurol. 2025 Nov 27:pn-2024-004473. doi: 10.1136/pn-2024-004473. Online ahead of print.

Expanding Therapeutic Horizons in Parkinson's Disease Through MicroRNA-Based Interventions: A Comprehensive Review

Bhamare UU, Talpade A, Pingili RB, Palkar MB.

Eur J Neurosci. 2025 Dec;62(11):e70343. doi: 10.1111/ejn.70343.

Sirtuins in Parkinson's disease: Molecular mechanisms and pathophysiological roles

Li X, Luo X, Cao X, Thomas ER, Wang W, Zhou X, Zhou S, Wu A, Gao R, Liu K, Wu J.

Ageing Res Rev. 2025 Dec;112:102902. doi: 10.1016/j.arr.2025.102902. Epub 2025 Sep 26.

Pharmacogenetics in advanced Parkinson's disease

Kulisevsky J, García-Ruíz P, Outeiro TF, Gurevich T, Klivènyi P, Van Laar T, Milanov I, Pirker W, Popescu BO, Toft M, Szász JA.

J Neural Transm (Vienna). 2025 Nov;132(11):1719-1726. doi: 10.1007/s00702-025-03057-0. Epub 2025 Nov 12.

The nosology of tardive parkinsonism

Calzetti S, Calzetti G.

J Clin Neurosci. 2025 Dec;142:111683. doi: 10.1016/j.jocn.2025.111683. Epub 2025 Oct 22.

Summarizing the Role of Selected Adipokines in Parkinson's Disease: What Is Known About Leptin, Adiponectin, Resistin, Visfatin, and Progranulin in Neurodegeneration?

Milanowski J, Pawłowska M, Woźniak A, Szewczyk-Golec K.

Molecules. 2025 Nov 16;30(22):4431. doi: 10.3390/molecules30224431.

Parkinson's disease and the gut-brain connection: unveiling pathways, mechanisms and promising therapies

Hajare S, Kulkarni YA.

Brain Res. 2025 Dec 1;1868:149975. doi: 10.1016/j.brainres.2025.149975. Epub 2025 Oct 4.

Protein aggregation in neurodegenerative diseases

Wang J, Dai L, Zhang Z.

Chin Med J (Engl). 2025 Nov 5;138(21):2753-2768. doi: 10.1097/CM9.0000000000003802. Epub 2025 Sep 16.